Overview

Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)

Status:
Withdrawn

Trial end date:
2016-11-01

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to evaluate the safety of Xarelto in the prophylaxis of VTE in Indian patients undergoing elective TKR/THR

Details

Lead Sponsor:

Bayer

Treatments:

Rivaroxaban